Conjugated linoleic acid (CLA): is it time to supplement asthma therapy?

TitleConjugated linoleic acid (CLA): is it time to supplement asthma therapy?
Publication TypeJournal Article
Year of Publication2011
AuthorsMacRedmond, R, Dorscheid, DR
JournalPulm Pharmacol Ther
Volume24
Issue5
Pagination540-8
Date Published2011 Oct
ISSN1522-9629
KeywordsAnimals, Anti-Asthmatic Agents, Asthma, Clinical Trials as Topic, Dietary Supplements, Drug Evaluation, Preclinical, Humans, Linoleic Acids, Conjugated
Abstract

The limitations and side effects of existing asthma therapies prompt interest in complementary and alternative therapies. Conjugated linoleic acids (CLA) are a family of natural fatty acids found primarily in beef and dairy products. These molecules have a variety of biological properties which suggest potential benefit in asthma, including effects on energy regulation, lipid metabolism, inflammation and immune function. Here we review the evidence for these effects from pre-clinical and clinical studies, their significance in the context of human asthma, and discuss the potential role for CLA supplementation in asthma management.

DOI10.1016/j.pupt.2011.03.005
Alternate JournalPulm Pharmacol Ther
PubMed ID21530672